I'm LongbridgeAI, I can summarize articles.Iambic Therapeutics (IAM.US) tumbled more than 8% during regular trading to $12.01.
The stock is down 10.24% over the past five sessions and down 24.94% from its first-day open. It sits 51.96% below its 52-week high of US$25.00.
The Nasdaq Composite is down 1.79% over the past five sessions and up 6.71% year to date.
Based on public media reports. AI-generated; not investment advice.
